• HOME
  • PARTNERS
  • NEWS
    • NEWSLETTER
  • JOINT CALLS
    • JOINT TRANSNATIONAL CALL 2022
    • JOINT TRANSNATIONAL CALL 2021
    • JOINT TRANSNATIONAL CALL 2020
    • JOINT TRANSNATIONAL CALL 2019
    • JOINT TRANSNATIONAL CALL 2018
  • FUNDED PROJECTS
  • EP PerMed
    • EP PerMed: Open Consultation for the SRIA
    • Draft Proposal “European Partnership on Personalised Medicine”
    • EP PerMed Information Day
    • EP PerMed Information Sheets
    • Guide to a European Partnership for Personalised Medicine
    • Draft Concept Paper “European Partnership for Personalised Medicine – EP PerMed”
  • PRIVACY
  • FOLLOW US
  • ACCESS FOR MEMBERS
02 Mar2023

ERA PerMed’s Final Symposium of the JTC2018 co-funded projects has just taken place in Cluj-Napoca – Feb 28 – Mar 1, 2023

Written by Mª Cristina Nieto. Posted in News

The first transnational call of ERA PerMed, JTC2018, was co-funded by the European Commission (EC) and in its framework, 25 projects were chosen to be funded with a total of approximately 25 million Euros. These projects involve 133 research groups from 18 different countries.

The overall aim of the call was to fund projects showing clinical feasibility of personalised medicine (PM) in various types of diseases ranging from complex/multifactorial diseases to monogenic diseases, including cancer, rare diseases, psychiatric disorders and more.  Clinical feasibility was defined in this call as the demonstration of significant and clinically relevant improvement of current diagnostics and/or therapeutics, based on improved understanding of underlying molecular mechanisms.

This Final symposium, which has taken place in Cluj-Napoca, Romania, is attended by 67 on-site participants, including researchers from the JTC2018 consortia, the ERA PerMed EC policy officer, representatives from funding organisations and scientific experts, as well as ~30 online participants. The symposium aims to provide the project coordinators with the opportunity to present and discuss their work and results, and promote interactions between the various stakeholders attending the meeting.

Furthermore, young researchers from the funded consortia were invited to communicate their research through a poster presentation and ten posters have been shown. ERA PerMed’s support and encouragement of young researchers is also demonstrated in the awards given to the winners of the best video competition and the best poster.

This event also serves as an opportunity to discuss the importance of patient and citizen involvement in PM research. A dedicated patient involvement panel was organised, presenting perspectives of the patients/citizens, the researchers and the funders.

Finally, this event also serves as a great opportunity for networking and fostering new ideas and collaborations, as well as presenting to the researchers the potential funding opportunities in PM field that can be fostered by the future European Partnership on Personalised Medicine (EP PerMed), which it is currently under preparation. 

The Symposium provided an excellent opportunity to learn about the outstanding results and outcomes of the JTC2018 EC co-funded projects, who managed to make admirable progress despite being greatly impacted in their work by the Covid-19 pandemic.

  • Continue Reading
19 Jan2023

Newsletter 9

Written by Mª Cristina Nieto. Posted in NEWSLETTER

ERA PerMed Results of the Joint Transnational Call 2022

It is our pleasure to announce the publication of our ERA PerMed 9th Newsletter where you can find the results of the ERA PerMed Joint Transnational Call 2022, in which 24 successful consortia have been funded with a total investment of approx. 30.2 M€ for 3 years.

More information can be found as well about other ERA PerMed activities, such as the video competition for young researchers in JTC2018 “the story behind our personalised medicine research project” or our Final Symposium for ERA PerMed JTC2018 co-funded projects that will be held in Romania in February 2023.

ERA PerMed 9th Newsletter January 2023.  

  • Continue Reading
07 Nov2022

The story behind our personalised medicine research project – video competition

Written by Mª Cristina Nieto. Posted in News

Welcome to the best video competition for young researchers of ERA PerMed’s co-funded Joint Transnational Call 2018 (JTC2018) on personalised medicine!

This competition was launched by ERA PerMed to provide a platform for the young researchers participating in the JTC2018 ERA PerMed co-funded call to showcase the fascinating cutting-edge research that they are performing on prominent topics in personlised medicine, while collaborating with multi-national research groups.

See below videos from nine of the JTC2018 funded consortia and feel free to vote for them by “liking” their video on YouTube. Voting is open until November 25th at 12:00 CET.

PersTIgAN

 

JAKSTAT-TARGET

PerProGlio

GEPARD

PROCEED

RADprecise

PERMEABLE

PersoProCaRisk

RAISE-GENIC

More information about 2018 Joint Co-Funded Call funded projects.

  • Continue Reading
28 Jul2022

Newsletter 8

Written by Mª Cristina Nieto. Posted in NEWSLETTER

ERA PerMed: News, Updates, Achievements and Future Plans

We are glad to announce the publication of our ERA PerMed 8th Newsletter where you can find interesting statistics on the ERA PerMed JTC2021 funded projects. 

It is also included information regarding PM- related events (e.g. ICPerMed Conference and other interesting events), information about our current JTC2022 and about the last developments of the future European Partnership for Personalised Medicine (EP PerMed) and the new CSA PROPHET on Personalised Prevention. 

ERA PerMed 8th   NewsLetter July 2022

  • Continue Reading
20 Jul2022

3rd ICPerMed conference: “Prelude to the Future of Medicine”

Written by Mª Cristina Nieto. Posted in News

Announcement of the 3rd ICPerMed conference: “Prelude to the Future of Medicine” on October 5-6, 2022 in Paris

The International Consortium for Personalised Medicine is pleased to invite you to the ICPerMed Conference “Prelude to the Future of Medicine” on October 5-6, 2022 in person in Paris, France.

The conference will provide insights into what the future of medicine will look like by presenting concrete examples of personalised medicine approaches and aspects already in practice. The conference will demonstrate that implementation of personalised medicine is progressing through all disciplines and medical fields and aims to inspire other initiatives to adopt similar approaches.

Come and learn more about:

  • Incorporating patient’s perspective in personalised healthcare
  • The future of personalised medicine in clinical trials settings
  • Challenges in developing health data governance
  • Creating a sustainable innovation environment for personalised medicine
  • Health economic benefits – beyond cost-effectiveness

Confirmed speakers:

  • Laura Navne, The Danish Centre for Social Science, VIVE, Denmark
  • Jillian Hasting-Ward, Genomics England, UK
  • Eyal Zimlichman, Sheba Medical Center, Israel
  • Laura Esserman, University of California, San Francisco (UCSF), USA
  • Markus Kalliola, TEHDAS, Finland
  • Laurent Essioux, Roche, Switzerland
  • Balázs Nagy, Semmelweis University, Hungary
  • Health Data Hub, France

More about the programme

As space is limited, we encourage you to register as soon as possible! Less than 100 seats are left for onsite participation.

The registration is free but mandatory (for virtual or onsite participation). Only the people registered for the virtual format will receive the connection access code and only the people registered for the onsite format will get an access badge.

Registration

  • Continue Reading
  • 1
  • 2
  • 3
  • 4
  • ...
  • 8

Please follow us on @ERANET_PerMed!

Instituto de Salud Carlos III


 height


This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 779282